To better understand and measure the effect of tumor cell enrichment on protein pathway profiling and drug target activation measurements, the signaling activation portraits of laser capture microdissected (LCM) cancer epithelium and tumor stroma were compared with patient-matched whole-tissue specimens from 53 primary colorectal cancer samples. Microdissected material and whole-tissue lysate from contiguous cryostat sections were subjected to reverse-phase protein microarray analysis to determine the level of phopshorylation and expression of 75 different proteins known to be involved in cancer progression. The results
revealed distinct HKI-272 in vitro differences in the protein activation portraits of cancer BAY 1895344 solubility dmso epithelium and stroma. Moreover, we found that the signaling activation profiles of the undissected whole-tissue specimens are profoundly different from the matched LCM material. Attempts to rescale the undissected pathway information based on percent endogenous tumor epithelium content were unsuccessful in recapitulating the LCM tumor epithelial signatures. Analysis of epidermal growth factor receptor phosphorylation and COX2 expression in these same sample sets revealed wholesale differences in the rank ordering of patient determination
when LCM was compared with undissected samples. On the basis of these data, we conclude that accurate protein pathway activation status, which is under evaluation as a basis for patient selection and stratification for personalized therapy, must include upfront cellular-enrichment techniques such as LCM to generate accurate drug target activation status. Laboratory Investigation (2010) 90, 787-796; doi:10.1038/labinvest.2010.47; published online 1 March 2010″
“Introduction: The possible effects of ractiocolloid preference on sentinel lymph node biopsy (SLNB) were investigated.
Methods: A total of 200 patients with T1-2N0M0 breast cancer were evaluated. The first 100 patients underwent SENB using (99m)Tc tin colloid (TC) and the next 100
using (99m)Tc nanocolloid (NC). Radiocolloid was injected intradermally at four quadrants of the periareolar E7080 nmr region the day before surgery. All patients underwent lymphoscintigraphy 1 h after injection. All nodes having fourfold activity of the background were harvested using gamma probe.
Results: Sentinel lymph node (SLN) identification rate by gamma probe was 98% in each group. The number of SLNs identified by lymphoscintigraphy, gamma probe and pathological evaluation was 1.39+/-0.7, 1.70+/-1.0 and 2.23+/-1.70 in the TC and 2.03+/-0.94, 2.60+/-1.36 and 3.05+/-1.90 in the NC group, respectively (P<.05). Metastatic SLN was found in 24 (24.4%) of 98 patients in the TC group and 41 (41.8%) of 98 patients in the NC group (P=.04). None of the patients showed dispersion to internal mammarian lymph nodes. Lymphatic vessel visualization was observed in eight (8.1%) of 98 TC patients and in 47 (47.9%) of 98 NC patients (P=.000).